Searchable abstracts of presentations at key conferences on calcified tissues

ba0003pp11 | Arthritis and other joint diseases: translational and clinical | ECTS2014

Multinucleated giant cells in synovia from people with rheumatoid arthritis or osteoarthritis

Prieto-Potin Ivan , Largo Raquel , Roman-Blas Jorge A , Herrero-Beaumont Gabriel , Walsh David A

Aims: To describe different multinucleated giant cell phenotypes and their associations with synovitis in people with rheumatoid arthritis (RA) or osteoarthritis (OA), and in an experimental model of chronic arthritis.Material and methods: A cross-sectional comparative study was performed on samples of knee synovia from age-matched patients with RA, OA, or non-arthritic post mortem (PM) controls. OA synovia were stratified by histological inflammation gr...

ba0002p119 | (1) | ICCBH2013

Depressive symptoms and bone mineral density in a cohort of portuguese adolescents: no association

Monjardino Teresa , Lourenco Sara , Lucas Raquel , Ramos Elisabete , Barros Henrique

Objective: Since depressive symptoms, which have been related to low bone quality in adulthood, may also be associated with suboptimal bone mineral accrual, we aim at quantify the association between depressive symptoms and bone mineral density (BMD) throughout adolescence.Methods: We analysed prospective data from 969 adolescents (56.2% girls) from a population-based cohort of urban adolescents, born in 1990, evaluated during the 2003/2004 and 2007/2008...

ba0001pp199 | Cell biology: osteoblasts and bone formation | ECTS2013

Effect of β-cryptoxanthin on the differentiation of human bone-marrow stromal stem-cells treated with pioglitazone

Casado-Diaz Antonio , Santiago-Mora Raquel , Dorado Gabriel , Quesada-Gomez Jose Manuel

Pioglitazone is a drug of the thiazolidinedione (TZD) class used to treat type 2 diabetes mellitus. TZD is an agonist of peroxisome proliferator-activated receptor γ (PPAR-γ) that improves insulin sensitivity, glucose and lipid metabolism and inflammation. However, TZD induces bone marrow adiposity with suppression of osteogenesis, that could contribute to bone loss and osteoporotic fractures. β-Cryptoxanthin is a carotenoid with antioxidant properties abundant ...

ba0001pp250 | Chondrocytes and cartilage | ECTS2013

In vitro effects of caffeine on the proliferation, apoptosis, and gene transcripts expression of chondrogenic differentiation in growth cartilage of rats

Reis Amanda Maria Sena , Raad Raquel Viana , de Melo Ocarino Natalia , Serakides Rogeria

Caffeine is a methylxanthine found in many foods and is widely consumed by the human population. Therefore, its effects and mechanisms in various tissues have been widely studied. But despite changing the postnatal bone growth, there are few studies about its effect on growth cartilage. The objective of this study was to evaluate the In vitro effects of caffeine on proliferation, apoptosis and gene transcripts expression of chondrogenic differentiation in growth carti...

ba0002p124 | (1) | ICCBH2013

Adipokines and bone turnover throughout adolescence: an exploratory approach in a cohort of girls

Monjardino Teresa , Ramos Elisabete , Lucas Raquel , Prata Margarida , Severo Milton , Rodrigues Ana , Canhao Helena , Fonseca Joao Eurico , Barros Henrique

Objectives: By prospectively evaluating a cohort of girls we aim to identify population patterns linking adipokines and bone turnover during early and late adolescence and to assess the associations of those patterns with forearm bone mineral density (BMD).Methods: The study was developed within a population-based cohort of urban adolescents born in 1990 and assembled in public and private schools of Porto, Portugal (EPITeen). We analysed prospective dat...

ba0003pp13 | Arthritis and other joint diseases: translational and clinical | ECTS2014

RANK expression is reduced in circulating monocytes from ankylosing spondylitis patients

Perpetuo Ines Pedro , Caetano-Lopes Joana , Vieira-Sousa Elsa , Campanilho-Marques Raquel , Ponte Cristina , Canhao Helena , Ainola Mari , Fonseca Joao Eurico

Rheumatoid arthritis (RA) and ankylosing spondylitis (AS) are systemic, immune-mediated diseases. RA’s main targets are the peripheral joints while AS has the axial skeleton and enthesis as the principal affected areas. RA is characterized by bone erosions and impaired repair whilst AS is typified by bone overgrowth. The causes for these differences are not yet understood; however we hypothesize that AS patients’ monocytes receive reduced osteoclastogenic stimuli and...

ba0001pp367 | Osteoporosis: pathophysiology and epidemiology | ECTS2013

Estimated glomerular filtration rate is associated with bone fragility in the elderly

Goncalves Maria Joao , Rodrigues Ana , Caetano-Lopes Joana , Raquel Emilia , Lopes Ana , Vidal Bruno , Vale Ana Catarina , Sarmento Marco , Vaz Maria Fatima , Monteiro Jacinto , Fonseca Joao Eurico , Canhao Helena

Introduction: Osteoporosis is frequently associated with renal disease, namely the bone metabolism disturbances caused by secondary hyperparathyroidism of chronic kidney disease (CKD). The increased risk of fragility fractures is well demonstrated in patients with end-stage renal disease (ESRD). There is recent evidence that bone pathological changes start early in the course of CKD. Our aim is to evaluate whether chronic renal disease, before ESRD, is associated with bone fra...

ba0001pp482 | Other diseases of bone and mineral metabolism | ECTS2013

Zoledronate efficacy and safety in active Paget's disease: long-term follow-up and retreatment in clinical practice

Vieira-Sousa Elsa , Rodrigues Ana , Caetano-Lopes Joana , Capela Susana , Ramos Filipa , Figueira Ricardo , Joaquim Polido-Pereira1 , Ponte Cristina , Raquel Campanilho-Marques1 , Barros Rita , Romeu Jose Carlos , da Silva Jose Alberto Pereira

Background: Zoledronate, a third generation bisphosphonate, has showed high efficacy in the inhibition of bone resorption. The objective of this observational study was to assess short and long-term efficacy and safety of zoledronate in the treatment of active Paget’s disease (PD).Methods: Patients with active PD treated with zoledronate 5 mg were consecutively recruited. Clinical and laboratory parameters were determined before, at 3 and every 6 mo...